Cardiol Therapeutics Inc. (TSX: CRDL.TO) Stock Competitors & Peer Comparison
See CRDL.TO's competitors and their performance on the TSX and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CRDL.TO and its TSX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CRDL.TO | CA$2.74 | +6.20% | 297.4M | -7.66 | -CA$0.34 | N/A |
| APTX.TO | CA$33.02 | -2.51% | 7.6B | 20.58 | CA$1.61 | N/A |
| CURA.CN | CA$5.22 | +9.21% | 4.1B | -6.07 | -CA$0.86 | N/A |
| BHC.TO | CA$9.02 | +2.27% | 3.5B | 2.50 | CA$3.69 | N/A |
| CURA.TO | CA$13.40 | -2.40% | 3.1B | 49.46 | CA$0.27 | N/A |
| TRUL.CN | CA$16.14 | -11.07% | 2.7B | -29.01 | -CA$0.56 | N/A |
| GTII.CN | CA$10.42 | -1.23% | 2.4B | 13.97 | CA$0.75 | N/A |
| VRNO.CN | CA$6.32 | +6.76% | 2.2B | -5.40 | -CA$1.17 | N/A |
| CRON.TO | CA$4.84 | +5.57% | 1.8B | 118.59 | CA$0.04 | N/A |
| GUD.TO | CA$9.83 | +1.76% | 948.4M | 64.17 | CA$0.15 | N/A |
Stock Comparison
Apotex Health Corp. (TSX: APTX.TO)
CRDL.TO vs APTX.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, APTX.TO has a market cap of 7.6B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while APTX.TO trades at CA$33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas APTX.TO's P/E ratio is 20.58. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to APTX.TO's ROE of -2.80%. Regarding short-term risk, CRDL.TO is more volatile compared to APTX.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check APTX.TO's competition here
Curaleaf Holdings, Inc. (CNQ: CURA.CN)
CRDL.TO vs CURA.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CURA.CN trades at CA$5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CURA.CN's ROE of -0.13%. Regarding short-term risk, CRDL.TO is less volatile compared to CURA.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check CURA.CN's competition here
Bausch Health Companies Inc. (TSX: BHC.TO)
CRDL.TO vs BHC.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BHC.TO has a market cap of 3.5B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BHC.TO trades at CA$9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BHC.TO's P/E ratio is 2.50. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BHC.TO's ROE of +0.88%. Regarding short-term risk, CRDL.TO is more volatile compared to BHC.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BHC.TO's competition here
Curaleaf Holdings, Inc. (TSX: CURA.TO)
CRDL.TO vs CURA.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CURA.TO has a market cap of 3.1B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CURA.TO trades at CA$13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CURA.TO's P/E ratio is 49.46. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CURA.TO's ROE of -0.05%. Regarding short-term risk, CRDL.TO is more volatile compared to CURA.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CURA.TO's competition here
Trulieve Cannabis Corp. (CNQ: TRUL.CN)
CRDL.TO vs TRUL.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TRUL.CN has a market cap of 2.7B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TRUL.CN trades at CA$16.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TRUL.CN's P/E ratio is -29.01. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TRUL.CN's ROE of -0.07%. Regarding short-term risk, CRDL.TO is less volatile compared to TRUL.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check TRUL.CN's competition here
Green Thumb Industries Inc. (CNQ: GTII.CN)
CRDL.TO vs GTII.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, GTII.CN has a market cap of 2.4B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while GTII.CN trades at CA$10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas GTII.CN's P/E ratio is 13.97. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to GTII.CN's ROE of +0.07%. Regarding short-term risk, CRDL.TO is more volatile compared to GTII.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check GTII.CN's competition here
Verano Holdings Corp. (CNQ: VRNO.CN)
CRDL.TO vs VRNO.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, VRNO.CN has a market cap of 2.2B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while VRNO.CN trades at CA$6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to VRNO.CN's ROE of -0.03%. Regarding short-term risk, CRDL.TO is less volatile compared to VRNO.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check VRNO.CN's competition here
Cronos Group Inc. (TSX: CRON.TO)
CRDL.TO vs CRON.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CRON.TO has a market cap of 1.8B. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CRON.TO trades at CA$4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CRON.TO's P/E ratio is 118.59. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CRON.TO's ROE of +0.06%. Regarding short-term risk, CRDL.TO is more volatile compared to CRON.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CRON.TO's competition here
Knight Therapeutics Inc. (TSX: GUD.TO)
CRDL.TO vs GUD.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, GUD.TO has a market cap of 948.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while GUD.TO trades at CA$9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas GUD.TO's P/E ratio is 64.17. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to GUD.TO's ROE of +0.02%. Regarding short-term risk, CRDL.TO is more volatile compared to GUD.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check GUD.TO's competition here
TerrAscend Corp. (CNQ: TER.CN)
CRDL.TO vs TER.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TER.CN has a market cap of 804.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TER.CN trades at CA$2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TER.CN's ROE of -0.44%. Regarding short-term risk, CRDL.TO is more volatile compared to TER.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TER.CN's competition here
Tilray Brands, Inc. (TSX: TLRY.TO)
CRDL.TO vs TLRY.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TLRY.TO has a market cap of 735.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TLRY.TO trades at CA$6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TLRY.TO's P/E ratio is -4.46. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TLRY.TO's ROE of -0.09%. Regarding short-term risk, CRDL.TO is more volatile compared to TLRY.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TLRY.TO's competition here
Verano Holdings Corp. (NEO: VRNO.NE)
CRDL.TO vs VRNO.NE Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, VRNO.NE has a market cap of 613.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while VRNO.NE trades at CA$8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas VRNO.NE's P/E ratio is -1.70. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to VRNO.NE's ROE of -0.35%. Regarding short-term risk, CRDL.TO is more volatile compared to VRNO.NE. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check VRNO.NE's competition here
Columbia Care Inc. (NEO: CCHW.NE)
CRDL.TO vs CCHW.NE Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CCHW.NE has a market cap of 407.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CCHW.NE trades at CA$1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CCHW.NE's P/E ratio is -3.52. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CCHW.NE's ROE of -1.07%. Regarding short-term risk, CRDL.TO is more volatile compared to CCHW.NE. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CCHW.NE's competition here
Cresco Labs Inc. (CNQ: CL.CN)
CRDL.TO vs CL.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CL.CN has a market cap of 382.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CL.CN trades at CA$1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CL.CN's P/E ratio is -2.66. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CL.CN's ROE of -0.28%. Regarding short-term risk, CRDL.TO is more volatile compared to CL.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CL.CN's competition here
Cipher Pharmaceuticals Inc. (TSX: CPH.TO)
CRDL.TO vs CPH.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CPH.TO has a market cap of 358M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CPH.TO trades at CA$14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CPH.TO's P/E ratio is 9.17. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CPH.TO's ROE of +0.23%. Regarding short-term risk, CRDL.TO is more volatile compared to CPH.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CPH.TO's competition here
Aurora Cannabis Inc. (TSX: ACB.TO)
CRDL.TO vs ACB.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, ACB.TO has a market cap of 338.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while ACB.TO trades at CA$5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas ACB.TO's P/E ratio is -2.82. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to ACB.TO's ROE of -0.05%. Regarding short-term risk, CRDL.TO is more volatile compared to ACB.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check ACB.TO's competition here
Auxly Cannabis Group Inc. (TSX: XLY.TO)
CRDL.TO vs XLY.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, XLY.TO has a market cap of 316.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while XLY.TO trades at CA$3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas XLY.TO's P/E ratio is 9.40. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to XLY.TO's ROE of +0.18%. Regarding short-term risk, CRDL.TO is more volatile compared to XLY.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check XLY.TO's competition here
Canopy Growth Corporation (TSX: WEED.TO)
CRDL.TO vs WEED.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, WEED.TO has a market cap of 265.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while WEED.TO trades at CA$1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas WEED.TO's P/E ratio is -2.36. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to WEED.TO's ROE of -0.30%. Regarding short-term risk, CRDL.TO is more volatile compared to WEED.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check WEED.TO's competition here
TerrAscend Corp. (TSX: TSND.TO)
CRDL.TO vs TSND.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TSND.TO has a market cap of 259.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TSND.TO trades at CA$0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TSND.TO's P/E ratio is -3.38. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TSND.TO's ROE of -0.46%. Regarding short-term risk, CRDL.TO is more volatile compared to TSND.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TSND.TO's competition here
Organigram Global Inc. (TSX: OGI.TO)
CRDL.TO vs OGI.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, OGI.TO has a market cap of 236.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while OGI.TO trades at CA$1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas OGI.TO's P/E ratio is -8.92. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to OGI.TO's ROE of +0.22%. Regarding short-term risk, CRDL.TO is more volatile compared to OGI.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check OGI.TO's competition here
Columbia Care Inc. (CNQ: CCHW.CN)
CRDL.TO vs CCHW.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CCHW.CN has a market cap of 228.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CCHW.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CCHW.CN's ROE of -1.07%. Regarding short-term risk, CRDL.TO is more volatile compared to CCHW.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CCHW.CN's competition here
Theratechnologies Inc. (TSX: TH.TO)
CRDL.TO vs TH.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TH.TO has a market cap of 205.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TH.TO trades at CA$4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TH.TO's P/E ratio is -17.19. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TH.TO's ROE of +0.17%. Regarding short-term risk, CRDL.TO is more volatile compared to TH.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TH.TO's competition here
Cannara Biotech Inc. (TSX: LOVE.TO)
CRDL.TO vs LOVE.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, LOVE.TO has a market cap of 197.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while LOVE.TO trades at CA$2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas LOVE.TO's P/E ratio is 17.32. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to LOVE.TO's ROE of +0.09%. Regarding short-term risk, CRDL.TO is more volatile compared to LOVE.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check LOVE.TO's competition here
Grown Rogue International Inc. (CNQ: GRIN.CN)
CRDL.TO vs GRIN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, GRIN.CN has a market cap of 165M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while GRIN.CN trades at CA$0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas GRIN.CN's P/E ratio is 40.07. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to GRIN.CN's ROE of -0.13%. Regarding short-term risk, CRDL.TO is more volatile compared to GRIN.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check GRIN.CN's competition here
BioHarvest Sciences Inc. (CNQ: BHSC.CN)
CRDL.TO vs BHSC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BHSC.CN has a market cap of 137.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BHSC.CN trades at CA$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BHSC.CN's ROE of +1.91%. Regarding short-term risk, CRDL.TO is more volatile compared to BHSC.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BHSC.CN's competition here
Jushi Holdings Inc. (CNQ: JUSH.CN)
CRDL.TO vs JUSH.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, JUSH.CN has a market cap of 129.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while JUSH.CN trades at CA$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas JUSH.CN's P/E ratio is -1.35. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to JUSH.CN's ROE of +0.53%. Regarding short-term risk, CRDL.TO is more volatile compared to JUSH.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check JUSH.CN's competition here
HLS Therapeutics Inc. (TSX: HLS.TO)
CRDL.TO vs HLS.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, HLS.TO has a market cap of 115.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while HLS.TO trades at CA$3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas HLS.TO's P/E ratio is -10.22. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to HLS.TO's ROE of -0.14%. Regarding short-term risk, CRDL.TO is more volatile compared to HLS.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check HLS.TO's competition here
Goodness Growth Holdings, Inc. (CNQ: GDNS.CN)
CRDL.TO vs GDNS.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, GDNS.CN has a market cap of 91M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while GDNS.CN trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to GDNS.CN's ROE of -0.13%. Regarding short-term risk, CRDL.TO is more volatile compared to GDNS.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check GDNS.CN's competition here
Charlotte's Web Holdings, Inc. (TSX: CWEB.TO)
CRDL.TO vs CWEB.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CWEB.TO has a market cap of 73.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CWEB.TO trades at CA$0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CWEB.TO's P/E ratio is -1.58. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CWEB.TO's ROE of -2.84%. Regarding short-term risk, CRDL.TO is more volatile compared to CWEB.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CWEB.TO's competition here
Vext Science, Inc. (CNQ: VEXT.CN)
CRDL.TO vs VEXT.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, VEXT.CN has a market cap of 71.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while VEXT.CN trades at CA$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas VEXT.CN's P/E ratio is -2.87. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to VEXT.CN's ROE of -0.25%. Regarding short-term risk, CRDL.TO is more volatile compared to VEXT.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check VEXT.CN's competition here
Planet 13 Holdings Inc. (CNQ: PLTH.CN)
CRDL.TO vs PLTH.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, PLTH.CN has a market cap of 62.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while PLTH.CN trades at CA$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas PLTH.CN's P/E ratio is -0.75. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to PLTH.CN's ROE of -1.32%. Regarding short-term risk, CRDL.TO is more volatile compared to PLTH.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check PLTH.CN's competition here
The Green Organic Dutchman Holdings Ltd. (CNQ: TGOD.CN)
CRDL.TO vs TGOD.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TGOD.CN has a market cap of 62.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TGOD.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TGOD.CN's ROE of +0.01%. Regarding short-term risk, CRDL.TO is more volatile compared to TGOD.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TGOD.CN's competition here
Leef Brands Inc. (CNQ: LEEF.CN)
CRDL.TO vs LEEF.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, LEEF.CN has a market cap of 58.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while LEEF.CN trades at CA$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas LEEF.CN's P/E ratio is -29.69. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to LEEF.CN's ROE of +2.07%. Regarding short-term risk, CRDL.TO is more volatile compared to LEEF.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check LEEF.CN's competition here
Stem Holdings, Inc. (CNQ: STEM.CN)
CRDL.TO vs STEM.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, STEM.CN has a market cap of 53.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while STEM.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas STEM.CN's P/E ratio is -0.00. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, CRDL.TO is more volatile compared to STEM.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check STEM.CN's competition here
C21 Investments Inc. (CNQ: CXXI.CN)
CRDL.TO vs CXXI.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CXXI.CN has a market cap of 45.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CXXI.CN trades at CA$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CXXI.CN's P/E ratio is -12.74. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CXXI.CN's ROE of -0.17%. Regarding short-term risk, CRDL.TO is less volatile compared to CXXI.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check CXXI.CN's competition here
MariMed Inc. (CNQ: MRMD.CN)
CRDL.TO vs MRMD.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MRMD.CN has a market cap of 43.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MRMD.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MRMD.CN's P/E ratio is -3.91. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MRMD.CN's ROE of -0.30%. Regarding short-term risk, CRDL.TO is more volatile compared to MRMD.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check MRMD.CN's competition here
BioNxt Solutions Inc. (CNQ: BNXT.CN)
CRDL.TO vs BNXT.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BNXT.CN has a market cap of 43.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BNXT.CN trades at CA$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BNXT.CN's P/E ratio is -6.10. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BNXT.CN's ROE of +1.11%. Regarding short-term risk, CRDL.TO is more volatile compared to BNXT.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BNXT.CN's competition here
HEXO Corp. (TSX: HEXO.TO)
CRDL.TO vs HEXO.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, HEXO.TO has a market cap of 38.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while HEXO.TO trades at CA$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, CRDL.TO is more volatile compared to HEXO.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check HEXO.TO's competition here
Waverunner Capital Inc. (CNQ: CHM.CN)
CRDL.TO vs CHM.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CHM.CN has a market cap of 37.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CHM.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CHM.CN's ROE of +1.16%. Regarding short-term risk, CRDL.TO is more volatile compared to CHM.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CHM.CN's competition here
iAnthus Capital Holdings, Inc. (CNQ: IAN.CN)
CRDL.TO vs IAN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, IAN.CN has a market cap of 34.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while IAN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas IAN.CN's P/E ratio is 7.94. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to IAN.CN's ROE of +0.50%. Regarding short-term risk, CRDL.TO is less volatile compared to IAN.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check IAN.CN's competition here
MediPharm Labs Corp. (TSX: LABS.TO)
CRDL.TO vs LABS.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, LABS.TO has a market cap of 31.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while LABS.TO trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas LABS.TO's P/E ratio is -3.47. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to LABS.TO's ROE of -0.14%. Regarding short-term risk, CRDL.TO is more volatile compared to LABS.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check LABS.TO's competition here
1CM Inc. (CNQ: EPIC.CN)
CRDL.TO vs EPIC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, EPIC.CN has a market cap of 30.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while EPIC.CN trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas EPIC.CN's P/E ratio is 7.08. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to EPIC.CN's ROE of +0.15%. Regarding short-term risk, CRDL.TO is less volatile compared to EPIC.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check EPIC.CN's competition here
MedMen Enterprises Inc. (CNQ: MMEN.CN)
CRDL.TO vs MMEN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MMEN.CN has a market cap of 27.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MMEN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, CRDL.TO is less volatile compared to MMEN.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check MMEN.CN's competition here
Mountain Valley MD Holdings Inc. (CNQ: MVMD.CN)
CRDL.TO vs MVMD.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MVMD.CN has a market cap of 24.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MVMD.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MVMD.CN's P/E ratio is -4.27. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MVMD.CN's ROE of -3.14%. Regarding short-term risk, CRDL.TO is more volatile compared to MVMD.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check MVMD.CN's competition here
YourWay Cannabis Brands Inc. (CNQ: YOUR.CN)
CRDL.TO vs YOUR.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, YOUR.CN has a market cap of 22.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while YOUR.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, CRDL.TO is more volatile compared to YOUR.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check YOUR.CN's competition here
Optimi Health Corp. (CNQ: OPTI.CN)
CRDL.TO vs OPTI.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, OPTI.CN has a market cap of 21.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while OPTI.CN trades at CA$6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas OPTI.CN's P/E ratio is -17.30. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to OPTI.CN's ROE of -0.84%. Regarding short-term risk, CRDL.TO is more volatile compared to OPTI.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check OPTI.CN's competition here
Mydecine Innovations Group Inc. (NEO: MYCO.NE)
CRDL.TO vs MYCO.NE Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MYCO.NE has a market cap of 21.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MYCO.NE trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MYCO.NE's P/E ratio is -0.54. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MYCO.NE's ROE of +0.02%. Regarding short-term risk, CRDL.TO is more volatile compared to MYCO.NE. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check MYCO.NE's competition here
Vinergy Capital Inc. (CNQ: VIN.CN)
CRDL.TO vs VIN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, VIN.CN has a market cap of 20.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while VIN.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to VIN.CN's ROE of -0.79%. Regarding short-term risk, CRDL.TO is not fully comparable compared to VIN.CN. This indicates unavailable risk data in terms of short-term price fluctuations for CRDL.TO.Check VIN.CN's competition here
Captiva Verde Wellness Corp. (CNQ: PWR.CN)
CRDL.TO vs PWR.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, PWR.CN has a market cap of 18.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while PWR.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas PWR.CN's P/E ratio is -15.79. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to PWR.CN's ROE of -0.83%. Regarding short-term risk, CRDL.TO is more volatile compared to PWR.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check PWR.CN's competition here
Ayr Wellness Inc. (CNQ: AYR-A.CN)
CRDL.TO vs AYR-A.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AYR-A.CN has a market cap of 18.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AYR-A.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AYR-A.CN's P/E ratio is -0.11. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AYR-A.CN's ROE of -0.75%. Regarding short-term risk, CRDL.TO is more volatile compared to AYR-A.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AYR-A.CN's competition here
Avicanna Inc. (TSX: AVCN.TO)
CRDL.TO vs AVCN.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AVCN.TO has a market cap of 17.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AVCN.TO trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AVCN.TO's P/E ratio is -6.33. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AVCN.TO's ROE of -1.08%. Regarding short-term risk, CRDL.TO is more volatile compared to AVCN.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AVCN.TO's competition here
IM Cannabis Corp. (CNQ: IMCC.CN)
CRDL.TO vs IMCC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, IMCC.CN has a market cap of 17.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while IMCC.CN trades at CA$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas IMCC.CN's P/E ratio is -2.68. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to IMCC.CN's ROE of -0.03%. Regarding short-term risk, CRDL.TO is less volatile compared to IMCC.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check IMCC.CN's competition here
EXMceuticals Inc. (CNQ: EXM.CN)
CRDL.TO vs EXM.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, EXM.CN has a market cap of 15.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while EXM.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, CRDL.TO is more volatile compared to EXM.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check EXM.CN's competition here
Crescita Therapeutics Inc. (TSX: CTX.TO)
CRDL.TO vs CTX.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CTX.TO has a market cap of 14.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CTX.TO trades at CA$0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CTX.TO's P/E ratio is -42.52. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CTX.TO's ROE of -0.02%. Regarding short-term risk, CRDL.TO is more volatile compared to CTX.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CTX.TO's competition here
Chalice Brands Ltd. (CNQ: CHAL.CN)
CRDL.TO vs CHAL.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CHAL.CN has a market cap of 14.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CHAL.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, CRDL.TO is more volatile compared to CHAL.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CHAL.CN's competition here
Red White & Bloom Brands Inc. (CNQ: RWB.CN)
CRDL.TO vs RWB.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, RWB.CN has a market cap of 14.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while RWB.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas RWB.CN's P/E ratio is -0.16. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to RWB.CN's ROE of +0.43%. Regarding short-term risk, CRDL.TO is more volatile compared to RWB.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check RWB.CN's competition here
RIV Capital Inc. (CNQ: RIV.CN)
CRDL.TO vs RIV.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, RIV.CN has a market cap of 13.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while RIV.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to RIV.CN's ROE of -1.13%. Regarding short-term risk, CRDL.TO is more volatile compared to RIV.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check RIV.CN's competition here
Greenway Greenhouse Cannabis Corporation (CNQ: GWAY.CN)
CRDL.TO vs GWAY.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, GWAY.CN has a market cap of 13.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while GWAY.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas GWAY.CN's P/E ratio is -15.38. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to GWAY.CN's ROE of -0.27%. Regarding short-term risk, CRDL.TO is more volatile compared to GWAY.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check GWAY.CN's competition here
Red Light Holland Corp. (CNQ: TRIP.CN)
CRDL.TO vs TRIP.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TRIP.CN has a market cap of 12.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TRIP.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TRIP.CN's P/E ratio is -2.80. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TRIP.CN's ROE of -0.41%. Regarding short-term risk, CRDL.TO is less volatile compared to TRIP.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check TRIP.CN's competition here
Orion Nutraceuticals Inc. (CNQ: ORI.CN)
CRDL.TO vs ORI.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, ORI.CN has a market cap of 11.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while ORI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to ORI.CN's ROE of +0.07%. Regarding short-term risk, CRDL.TO is more volatile compared to ORI.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check ORI.CN's competition here
Revive Therapeutics Ltd. (CNQ: RVV.CN)
CRDL.TO vs RVV.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, RVV.CN has a market cap of 10.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while RVV.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas RVV.CN's P/E ratio is -17.86. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to RVV.CN's ROE of +2.89%. Regarding short-term risk, CRDL.TO is less volatile compared to RVV.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check RVV.CN's competition here
Avant Brands Inc. (TSX: AVNT.TO)
CRDL.TO vs AVNT.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AVNT.TO has a market cap of 10.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AVNT.TO trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AVNT.TO's P/E ratio is -0.71. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AVNT.TO's ROE of -0.50%. Regarding short-term risk, CRDL.TO is more volatile compared to AVNT.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AVNT.TO's competition here
CanaFarma Hemp Products Corp. (CNQ: CNFA.CN)
CRDL.TO vs CNFA.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CNFA.CN has a market cap of 9.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CNFA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, CRDL.TO is more volatile compared to CNFA.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CNFA.CN's competition here
VIVO Cannabis Inc. (TSX: VIVO.TO)
CRDL.TO vs VIVO.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, VIVO.TO has a market cap of 9.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while VIVO.TO trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, CRDL.TO is less volatile compared to VIVO.TO. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check VIVO.TO's competition here
CLS Holdings USA, Inc. (CNQ: CLSH.CN)
CRDL.TO vs CLSH.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CLSH.CN has a market cap of 8.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CLSH.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CLSH.CN's P/E ratio is 3.50. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CLSH.CN's ROE of +0.37%. Regarding short-term risk, CRDL.TO is more volatile compared to CLSH.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CLSH.CN's competition here
Aleafia Health Inc. (TSX: AH.TO)
CRDL.TO vs AH.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AH.TO has a market cap of 8.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AH.TO trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, CRDL.TO is less volatile compared to AH.TO. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check AH.TO's competition here
Australis Capital Inc. (CNQ: AUSA.CN)
CRDL.TO vs AUSA.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AUSA.CN has a market cap of 7.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AUSA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AUSA.CN's P/E ratio is -0.32. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AUSA.CN's ROE of -1.15%. Regarding short-term risk, CRDL.TO is more volatile compared to AUSA.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AUSA.CN's competition here
StateHouse Holdings Inc. (CNQ: STHZ.CN)
CRDL.TO vs STHZ.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, STHZ.CN has a market cap of 7.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while STHZ.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to STHZ.CN's ROE of +0.36%. Regarding short-term risk, CRDL.TO is more volatile compared to STHZ.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check STHZ.CN's competition here
Christina Lake Cannabis Corp. (CNQ: CLC.CN)
CRDL.TO vs CLC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CLC.CN has a market cap of 7.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CLC.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CLC.CN's P/E ratio is 12.50. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CLC.CN's ROE of -0.31%. Regarding short-term risk, CRDL.TO is less volatile compared to CLC.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check CLC.CN's competition here
Blueberries Medical Corp. (CNQ: BBM.CN)
CRDL.TO vs BBM.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BBM.CN has a market cap of 7.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BBM.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BBM.CN's P/E ratio is -4.95. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BBM.CN's ROE of -1.92%. Regarding short-term risk, CRDL.TO is more volatile compared to BBM.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BBM.CN's competition here
Sproutly Canada Inc. (CNQ: SPR.CN)
CRDL.TO vs SPR.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, SPR.CN has a market cap of 7.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while SPR.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas SPR.CN's P/E ratio is -0.49. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to SPR.CN's ROE of +18.75%. Regarding short-term risk, CRDL.TO is more volatile compared to SPR.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check SPR.CN's competition here
Mojave Brands Inc. (CNQ: MOJO.CN)
CRDL.TO vs MOJO.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MOJO.CN has a market cap of 7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MOJO.CN trades at CA$0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MOJO.CN's P/E ratio is -8.45. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MOJO.CN's ROE of -0.77%. Regarding short-term risk, CRDL.TO is more volatile compared to MOJO.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check MOJO.CN's competition here
Nextleaf Solutions Ltd. (CNQ: OILS.CN)
CRDL.TO vs OILS.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, OILS.CN has a market cap of 6.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while OILS.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas OILS.CN's P/E ratio is -4.72. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to OILS.CN's ROE of -0.30%. Regarding short-term risk, CRDL.TO is more volatile compared to OILS.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check OILS.CN's competition here
Sweet Earth Holdings Corporation (CNQ: SE.CN)
CRDL.TO vs SE.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, SE.CN has a market cap of 6.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while SE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas SE.CN's P/E ratio is -0.60. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to SE.CN's ROE of -15.22%. Regarding short-term risk, CRDL.TO is more volatile compared to SE.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check SE.CN's competition here
Sunniva Inc. (CNQ: SNN.CN)
CRDL.TO vs SNN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, SNN.CN has a market cap of 6.1M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while SNN.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas SNN.CN's P/E ratio is -0.13. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to SNN.CN's ROE of -0.49%. Regarding short-term risk, CRDL.TO is more volatile compared to SNN.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check SNN.CN's competition here
CordovaCann Corp. (CNQ: CDVA.CN)
CRDL.TO vs CDVA.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CDVA.CN has a market cap of 5.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CDVA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CDVA.CN's P/E ratio is -1.09. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CDVA.CN's ROE of +0.44%. Regarding short-term risk, CRDL.TO is less volatile compared to CDVA.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check CDVA.CN's competition here
1933 Industries Inc. (CNQ: TGIF.CN)
CRDL.TO vs TGIF.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TGIF.CN has a market cap of 5.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TGIF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TGIF.CN's P/E ratio is 4.27. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TGIF.CN's ROE of -0.12%. Regarding short-term risk, CRDL.TO is less volatile compared to TGIF.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check TGIF.CN's competition here
Willow Biosciences Inc. (TSX: WLLW.TO)
CRDL.TO vs WLLW.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, WLLW.TO has a market cap of 5.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while WLLW.TO trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas WLLW.TO's P/E ratio is -0.22. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to WLLW.TO's ROE of +0.00%. Regarding short-term risk, CRDL.TO is less volatile compared to WLLW.TO. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check WLLW.TO's competition here
The BC Bud Corporation (CNQ: BCBC.CN)
CRDL.TO vs BCBC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BCBC.CN has a market cap of 5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BCBC.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BCBC.CN's ROE of -1.93%. Regarding short-term risk, CRDL.TO is less volatile compared to BCBC.CN. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check BCBC.CN's competition here
Heritage Cannabis Holdings Corp. (CNQ: CANN.CN)
CRDL.TO vs CANN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CANN.CN has a market cap of 4.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CANN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CANN.CN's P/E ratio is -0.22. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, CRDL.TO is more volatile compared to CANN.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CANN.CN's competition here
Bhang Inc. (CNQ: BHNG.CN)
CRDL.TO vs BHNG.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BHNG.CN has a market cap of 4.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BHNG.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BHNG.CN's P/E ratio is -0.94. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BHNG.CN's ROE of +4.00%. Regarding short-term risk, CRDL.TO is more volatile compared to BHNG.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BHNG.CN's competition here
4Front Ventures Corp. (CNQ: FFNT.CN)
CRDL.TO vs FFNT.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, FFNT.CN has a market cap of 4.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while FFNT.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to FFNT.CN's ROE of +7.89%. Regarding short-term risk, CRDL.TO is more volatile compared to FFNT.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check FFNT.CN's competition here
Luff Enterprises Ltd. (CNQ: LUFF.CN)
CRDL.TO vs LUFF.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, LUFF.CN has a market cap of 4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while LUFF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, CRDL.TO is not fully comparable compared to LUFF.CN. This indicates unavailable risk data in terms of short-term price fluctuations for CRDL.TO.Check LUFF.CN's competition here
Filament Health Corp. (NEO: FH.NE)
CRDL.TO vs FH.NE Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, FH.NE has a market cap of 3.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while FH.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas FH.NE's P/E ratio is -0.50. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to FH.NE's ROE of -1.38%. Regarding short-term risk, CRDL.TO is less volatile compared to FH.NE. This indicates lower risk in terms of short-term price fluctuations for CRDL.TO.Check FH.NE's competition here
Body and Mind Inc. (CNQ: BAMM.CN)
CRDL.TO vs BAMM.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, BAMM.CN has a market cap of 3.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while BAMM.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas BAMM.CN's P/E ratio is -0.01. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to BAMM.CN's ROE of +65.27%. Regarding short-term risk, CRDL.TO is more volatile compared to BAMM.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check BAMM.CN's competition here
TILT Holdings Inc. (NEO: TILT.NE)
CRDL.TO vs TILT.NE Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, TILT.NE has a market cap of 3.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while TILT.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to TILT.NE's ROE of +0.45%. Regarding short-term risk, CRDL.TO is more volatile compared to TILT.NE. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check TILT.NE's competition here
Refined Metals Corp. (CNQ: RMC.CN)
CRDL.TO vs RMC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, RMC.CN has a market cap of 3.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while RMC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to RMC.CN's ROE of +1.25%. Regarding short-term risk, CRDL.TO is more volatile compared to RMC.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check RMC.CN's competition here
THC Biomed Intl Ltd. (CNQ: THC.CN)
CRDL.TO vs THC.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, THC.CN has a market cap of 3.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while THC.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas THC.CN's P/E ratio is -0.89. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to THC.CN's ROE of -0.37%. Regarding short-term risk, CRDL.TO is more volatile compared to THC.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check THC.CN's competition here
North Bud Farms Inc. (CNQ: NBUD.CN)
CRDL.TO vs NBUD.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, NBUD.CN has a market cap of 3.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while NBUD.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to NBUD.CN's ROE of -0.27%. Regarding short-term risk, CRDL.TO is more volatile compared to NBUD.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check NBUD.CN's competition here
ManifestSeven Holdings Corporation (CNQ: MSVN.CN)
CRDL.TO vs MSVN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, MSVN.CN has a market cap of 2.9M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while MSVN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, CRDL.TO is more volatile compared to MSVN.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check MSVN.CN's competition here
AREV Life Sciences Global Corp. (CNQ: AREV.CN)
CRDL.TO vs AREV.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AREV.CN has a market cap of 2.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AREV.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AREV.CN's P/E ratio is -98.90. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, CRDL.TO is more volatile compared to AREV.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AREV.CN's competition here
Acerus Pharmaceuticals Corporation (TSX: ASP.TO)
CRDL.TO vs ASP.TO Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, ASP.TO has a market cap of 2.8M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while ASP.TO trades at CA$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, CRDL.TO is more volatile compared to ASP.TO. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check ASP.TO's competition here
Craftport Cannabis Corp. (CNQ: CFT.CN)
CRDL.TO vs CFT.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CFT.CN has a market cap of 2.7M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CFT.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CFT.CN's ROE of -2.12%. Regarding short-term risk, CRDL.TO is more volatile compared to CFT.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CFT.CN's competition here
Isracann Biosciences Inc. (CNQ: IPOT.CN)
CRDL.TO vs IPOT.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, IPOT.CN has a market cap of 2.6M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while IPOT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas IPOT.CN's P/E ratio is -3.41. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to IPOT.CN's ROE of -2.22%. Regarding short-term risk, CRDL.TO is more volatile compared to IPOT.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check IPOT.CN's competition here
Aion Therapeutic Inc. (CNQ: AION.CN)
CRDL.TO vs AION.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, AION.CN has a market cap of 2.5M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while AION.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas AION.CN's P/E ratio is -1.09. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to AION.CN's ROE of +1.91%. Regarding short-term risk, CRDL.TO is more volatile compared to AION.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check AION.CN's competition here
Flower One Holdings Inc. (CNQ: FONE.CN)
CRDL.TO vs FONE.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, FONE.CN has a market cap of 2.4M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while FONE.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas FONE.CN's P/E ratio is -0.10. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to FONE.CN's ROE of +8.32%. Regarding short-term risk, CRDL.TO is more volatile compared to FONE.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check FONE.CN's competition here
Choom Holdings Inc. (CNQ: CHOO.CN)
CRDL.TO vs CHOO.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CHOO.CN has a market cap of 2.3M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CHOO.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CHOO.CN's P/E ratio is -0.10. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CHOO.CN's ROE of +4.09%. Regarding short-term risk, CRDL.TO is more volatile compared to CHOO.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CHOO.CN's competition here
West Island Brands Inc. (CNQ: WIB.CN)
CRDL.TO vs WIB.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, WIB.CN has a market cap of 2.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while WIB.CN trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas WIB.CN's P/E ratio is -0.39. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to WIB.CN's ROE of -1.00%. Regarding short-term risk, CRDL.TO is more volatile compared to WIB.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check WIB.CN's competition here
CBD Global Sciences Inc. (CNQ: CBDN.CN)
CRDL.TO vs CBDN.CN Comparison August 2026
Cardiol Therapeutics Inc. (TSX: CRDL.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRDL.TO stands at 297.4M. In comparison, CBDN.CN has a market cap of 2.2M. Regarding current trading prices, CRDL.TO is priced at CA$2.74 on the TSX, while CBDN.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRDL.TO currently has a P/E ratio of -7.66, whereas CBDN.CN's P/E ratio is -0.25. In terms of profitability, CRDL.TO's ROE is -1.80%, compared to CBDN.CN's ROE of +1.16%. Regarding short-term risk, CRDL.TO is more volatile compared to CBDN.CN. This indicates higher risk in terms of short-term price fluctuations for CRDL.TO.Check CBDN.CN's competition here